REQUEST A DEMO
Total
USD $0.00
Search more companies

Spolpharma, S.R.O. (Czech Republic)

Main Activities: Chemical and Allied Products Merchant Wholesalers | Other Chemical and Allied Products Merchant Wholesalers
Secondary Activities: All Other Miscellaneous Chemical Product and Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | General Merchandise Stores, including Warehouse Clubs and Supercenters | Other Miscellaneous Store Retailers | Testing Laboratories
Full name: Spolpharma, S.R.O. Profile Updated: October 21, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Spolpharma, S.R.O. is an enterprise located in Czech Republic, with the main office in Usti nad Labem. It operates in the Chemical and Allied Products Merchant Wholesalers industry. The company was established on February 08, 2006. 6 - 9 (2025) employees currently work for Spolpharma, S.R.O.. The company’s latest financial report indicates a net sales revenue increase of 63% in 2023. During that time, Spolpharma, S.R.O.’s total assets grew by 37.9%.

Headquarters
Na Luhach 3420/12
Usti nad Labem; Ustecky; Postal Code: 40001

Contact Details: Purchase the Spolpharma, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Spolpharma, S.R.O. report to view the information.
Registered Capital:
Purchase the Spolpharma, S.R.O. report to view the information.
Financial Auditors:
Purchase the Spolpharma, S.R.O. report to view the information.
Incorporation Date:
February 08, 2006
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Spolpharma, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
63%
Total operating revenue
84.44%
Operating profit (EBIT)
48.85%
EBITDA
97.54%
Net Profit (Loss) for the Period
64.06%
Total assets
37.9%
Total equity
7.79%
Operating Profit Margin (ROS)
-0.24%
Net Profit Margin
0%
Return on Equity (ROE)
2.48%
Quick Ratio
3.69%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?